Clinical Trials Directory

Trials / Completed

CompletedNCT05866263

Investigation of the Effect on Cognitive Skills of COVID-19 Survivors

Investigation of the Effect Of Green Walking and Intelligence Games on the Cognitive Skills of Individuals Between the Ages of 50-70 Survived COVID-19 Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Bayburt University · Academic / Other
Sex
All
Age
50 Years – 70 Years
Healthy volunteers
Accepted

Summary

Investigation of the Effect Of Green Walking and Intelligence Games on the Cognitive Skills of Individuals Between the Ages of 50-70 Survived COVID-19 Disease The randomized controlled study to examine the effects of green walking and intelligence games on the cognitive skills of individuals aged 50-70 years who had COVID-19 on an outpatient basis were completed with 40 individuals, 20 of which were in the green walking and intelligence game group and 20 were in the control group.

Detailed description

The data were collected in Erzincan Tercan State Hospital between January-May 2022, "Patient Information Form," "Montreal Cognitive Assessment Implementation Guideline," "Brain Games (Brain Games-Memory Thinking and Brain Exercise) Information Leaflet," "Hiking Information Brochure," and "Experimental Group Follow-up Form" by the "Montreal Cognitive Assessment Scale" applied as a pre-test. As an initiative, the green walking and intelligence game group was given a 30-minute nature walk three days a week for a month and a 15-minute intelligence game practice every day. Then, the "Montreal Cognitive Assessment Scale" was applied as a post-test.

Conditions

Interventions

TypeNameDescription
OTHERgreen walking and intelligence gamThe randomized controlled study to examine the effects of green walking and intelligence games on the cognitive skills of individuals aged 50-70 years who had COVID-19 on an outpatient basis were completed with 40 individuals, 20 of which were in the green walking and intelligence game group and 20 were in the control group.

Timeline

Start date
2021-03-23
Primary completion
2022-01-03
Completion
2022-05-17
First posted
2023-05-19
Last updated
2023-05-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05866263. Inclusion in this directory is not an endorsement.